KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

VivoSim Labs (VIVS) EBITDA (2016 - 2025)

VivoSim Labs (VIVS) has 16 years of EBITDA data on record, last reported at -$2.8 million in Q4 2025.

  • For Q4 2025, EBITDA rose 20.24% year-over-year to -$2.8 million; the TTM value through Dec 2025 reached -$1.4 million, up 89.04%, while the annual FY2025 figure was -$2.5 million, 83.04% up from the prior year.
  • EBITDA reached -$2.8 million in Q4 2025 per VIVS's latest filing, down from -$2.5 million in the prior quarter.
  • Across five years, EBITDA topped out at $6.9 million in Q1 2025 and bottomed at -$7.5 million in Q1 2023.
  • Average EBITDA over 5 years is -$2.8 million, with a median of -$3.2 million recorded in 2022.
  • Peak YoY movement for EBITDA: plummeted 290.37% in 2023, then soared 324.95% in 2025.
  • A 5-year view of EBITDA shows it stood at -$3.5 million in 2021, then increased by 6.83% to -$3.3 million in 2022, then dropped by 10.52% to -$3.6 million in 2023, then increased by 4.33% to -$3.4 million in 2024, then increased by 20.24% to -$2.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$2.8 million in Q4 2025, -$2.5 million in Q3 2025, and -$2.9 million in Q2 2025.